Bank of New York Mellon Corp Boosts Investment in Medpace Holdings, (NASDAQ:MEDP)
April 1, 2023
Trending News ☀️
Medpace Holdings ($NASDAQ:MEDP), Inc. (NASDAQ:MEDP) is a leading global full-service clinical research organization that provides comprehensive, customized clinical research services to biopharmaceutical and medical device sponsors. The company offers a broad range of therapeutic areas and services, allowing them to design and implement clinical projects that are tailored to the specific objectives of their sponsors. Recently, Bank of New York Mellon Corp has increased its stake in Medpace Holdings, Inc. (NASDAQ:MEDP). The increased investment by Bank of New York Mellon Corp is seen as a vote of confidence in the future of Medpace Holdings, Inc., and its ability to deliver on its goals of providing comprehensive and customized clinical research services for its sponsors.
This increased investment in Medpace Holdings, Inc. is expected to further strengthen the company’s position in the competitive clinical research market, allowing them to continue to provide quality services to its sponsors and build upon their already successful track record. With its strong financial backing from Bank of New York Mellon Corp, Medpace Holdings, Inc. looks poised to make even greater strides in its mission to deliver effective and reliable clinical research solutions for its sponsors.
Price History
With this purchase, MEDPACE HOLDINGS stock opened at $178.8 and closed at $181.9, up by 0.8% from last closing price of 180.5. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Medpace Holdings. More…
| Total Revenues | Net Income | Net Margin |
| 1.46k | 245.21 | 16.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Medpace Holdings. More…
| Operations | Investing | Financing |
| 388.05 | -38.74 | -775.77 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Medpace Holdings. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.35k | 966.11 | 12.43 |
Key Ratios Snapshot
Some of the financial key ratios for Medpace Holdings are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 19.2% | 29.9% | 19.1% |
| FCF Margin | ROE | ROA |
| 24.1% | 47.3% | 12.9% |
Analysis
At GoodWhale, we have conducted a thorough analysis of MEDPACE HOLDINGS’s fundamentals. Our Risk Rating shows that it is a high risk investment when it comes to financial and business aspects. We have noticed two risk warnings in the income sheet that could affect potential investors. To find out more, register at goodwhale.com and check it out. Our experienced analysts will be on hand to provide you with more information about MEDPACE HOLDINGS and help you make an informed decision. More…
Peers
Medpace’s services include clinical trial management, data management, biostatistics, and medical writing. Medpace’s competitors include Icon PLC, Syneos Health Inc, and IQVIA Holdings Inc.
– Icon PLC ($NASDAQ:ICLR)
Icon PLC is a publicly traded company with a market capitalization of $14.59 billion as of March 2022. The company has a return on equity of 4.28%. Icon is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company has a network of over 80 sites in 40 countries. Icon’s services include clinical research, regulatory affairs, quality management, data management, and biostatistics.
– Syneos Health Inc ($NASDAQ:SYNH)
Synoes Health Inc is a pharmaceutical company with a market cap of 4.81B as of 2022. The company has a Return on Equity of 9.89%. The company develops, manufactures, and sells pharmaceutical products. The company’s products include prescription drugs, over-the-counter drugs, and medical devices. The company operates in the United States, Europe, and Asia.
– IQVIA Holdings Inc ($NYSE:IQV)
IQVIA Holdings Inc is a global healthcare company that provides market research, data, and analytics solutions to help customers drive healthcare transformation and growth. The company’s market cap as of 2022 is 33.49B, and its ROE is 19.29%. IQVIA’s customers include healthcare payers and providers, pharmaceutical and biotech companies, and government agencies. The company’s solutions help its customers drive healthcare transformation by improving patient outcomes, reducing costs, and increasing access to care.
Summary
Investors have shown increased confidence in Medpace Holdings, Inc. (NASDAQ:MEDP) as Bank of New York Mellon Corp has recently raised its stake in the company. Recent analysis suggests that MEDP is well-positioned to benefit from the current economic climate, with shares performing strongly compared to its peers. The company’s focus on providing clinical research and development services has positioned it to benefit from growth in this sector, as more pharmaceutical companies outsource their research and development needs.
The company also has a strong balance sheet, with low debt levels and strong cash flow. This makes MEDP an attractive investment option for investors looking for a stable growth prospect.
Related Posts
Recent Posts
